The lymphoma cell line LSTRA contains an elevated level of tyrosine protein kinase activity. It has been suggested that this elevated level of activity is due to the presence of a phosphoprotein with a molecular weight of 56,000 (pp56, formerly referred to as a 58,000-dalton protein). This paper describes the preparation of antibodies against pp56 through the use of a synthetic peptide that contains the sequence around the site of tyrosine phosphorylation in pp56, which is identical to the phosphorylation site in pp6jSrc. These antipeptide antibodies specifically immunoprecipitated 32P-labeled pp56 from detergent extracts of LSTRA cells. In immunoblotting experiments, pp56 was the major antigen detected in the particulate fraction from LSTRA cells by the antipeptide antibodies. The antibodies were also used to show that the level of pp56 is greatly elevated in LSTRA cells. Incubation of the detergent extract of the particulate fraction from LSTRA cells with the antipeptide antibodies resulted in inhibition of most of the LSTRA cell tyrosine protein kinase activity. These results indicate that ppS6 is the tyrosine protein kinase whose activity is elevated in LSTRA cells. This enzyme may be a member of the large family of protein kinases involved in the regulation of cell growth.
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Protein kinases that phosphorylate tyrosine residues may be intimately involved in the regulation of cell growth. The receptors for four different polypeptide mitogens-epidermal growth factor, platelet-derived growth factor, insulin, and somatomedin C-each possess tyrosine protein kinase activity that is specifically stimulated by the appropriate growth factor (1) (2) (3) (4) (5) . Treatment of quiescent fibroblasts with a variety of mitogenic agents, such as tumor promoters, growth factors, and proteases, resulted in an increased phosphorylation of protein tyrosine residues (6) (7) (8) , implying that these different agents may all stimulate cell division by increasing the intracellular activity of a tyrosine protein kinase. The importance of tyrosine protein kinases in the control of cellular proliferation is further emphasized by the finding that the oncogenes of a large number of RNA tumor viruses code for several different tyrosine protein kinases (see ref. 9 for a recent review).
The number of tyrosine protein kinases present in eukaryotic cells is not known. Investigators have described about 10 distinct enzymes (9) . The Moloney leukemia virus-transformed cell line LSTRA contains an elevated level of a potentially distinct tyrosine protein kinase (10) (11) (12) . We have suggested that this kinase is a protein with a molecular weight of 56,000 (pp56)11 (11, 12) , based on the observation that the amino acid sequence around an in vitro site of tyrosine phosphorylation in pp56 is identical to the sequence around the site of tyrosine phosphorylation in the viral enzymes pp6Osrc, the transforming protein of Rous sarcoma virus, and pp9W'agYes, the transforming protein of the Y73 virus (11) . Studies of lymphocytes isolated from mouse spleen have shown that pp56 is the product of a cellular gene, since an identical protein is present in normal T lymphocytes (12) . However, pp56 appears to be present at a much higher level in LSTRA cells than in T lymphocytes, in congruence with the much higher level of tyrosine protein kinase activity in the LSTRA cells (12) . Other workers have suggested that pp56 may be the major tyrosine protein kinase that can be isolated from rat spleen (13) .
Identification of the sequence around the site of phosphorylation in pp56 permits the production of antibodies to pp56 through the use of a synthetic peptide with the same sequence. In this paper, we report the production of these antibodies and the observation that their interaction with pp56 inhibits most of the tyrosine protein kinase activity in detergent extracts from LSTRA cells. These data provide strong evidence that pp56 is a tyrosine protein kinase and that the elevated level of this protein in LSTRA cells is responsible for the elevated level of tyrosine protein kinase activity in these cells.
MATERIALS AND METHODS
Materials. Microtiter plates were obtained from Dynatech (Alexandria, VA). Protein A-alkaline phosphatase conjugate and fixed Staphylococcus aureus were from Zymed Laboratories (Burlingame, CA). Nitrocellulose sheets were from Schleicher & Schuell and 125I-labeled goat anti-rabbit IgG was obtained from New England Nuclear. Cell culture materials, reagents for synthetic peptide synthesis, and all other reagents were obtained as previously reported (10) (11) (12) 14) .
Production of Antibodies. The peptide Lys-Arg-Leu-IleGlu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly was synthesized by solid-phase methods as described (10, 14) . This peptide contains the sequence around the site of tyrosine phosphorylation in pp60src (15) (16) (17) (18) jections (14, 19) . The titer against the peptide was measured by ELISA, using peptide conjugated to bovine serum albumin (BSA) as the antigen. The antibody-antigen complexes were detected using alkaline phosphatase conjugated to protein A. The alkaline phosphatase activity was measured using 5 mM p-nitrophenylphosphate/0.75 M 2-amino-2-methylpropanediol, pH 10.3/1 mM MgC12.
The IgG fraction from the serum was precipitated with ammonium sulfate at 50% saturation. The precipitate was dissolved in phosphate-buffered saline (about one-fifth the volume of the original serum) and applied to a peptide-Sepharose column. After the column was washed with 0.5 M KCI to remove nonspecifically bound proteins, the peptide-specific antibodies were eluted with 0.2 M glycine HCl, pH 2.8. Fractions were collected into 1 M Tris'HCJ, pH 8.0, to immediately neutralize the eluate. The fractions containing significant absorbance at 280 nm were pooled, dialyzed against phosphate-buffered saline, and concentrated by dialysis against 2 M sucrose.
Immunoprecipitation and Immunoblotting. Pellets were obtained from the LSTRA and YAC-1 cells by high-speed centrifugation as described (10) . The pp56 was phosphorylated by incubating the particulate fraction from LSTRA cells with [y_32PJATP (10) . The 32P-labeled pp56 was solubilized by detergent (10) (11) (12) , and the detergent extract was incubated with antipeptide antibodies for 4 hr at 0C. The immunocomplexes were collected with fixed S. aureus, which were then washed with high salt (14) to remove nonspecifically bound proteins, dispersed in sodium dodecyl sulfate gel electrophoresis sample buffer, heated in a boiling water bath for 2-3 min, and subjected to sodium dodecyl sulfate gel electrophoresis and autoradiography.
Immunoblotting was carried out essentially as described (14), except that the immunocomplexes were detected by the use of 125I-labeled goat anti-rabbit IgG.
Tyrosine Protein Kinase Assay. This was performed using the phosphocellulose filter-paper assay (10, 12) , except that the peptide used to elicit antibodies was also used as the substrate for the tyrosine protein kinase. The final concentration of peptide in the assay was 2.5 mM. When samples were assayed for kinase activity after preincubation with antibodies that had been blocked with synthetic peptide, the amount of peptide added for the kinase assay was reduced to compensate for the amount of peptide already in the sample. It was assumed that the synthetic peptide concentration was not significantly reduced by binding to the antibody. The recovery of almost all of the activity in these samples appears to justify this assumption.
RESULTS
Production of Antipeptide Antibodies. Four rabbits were injected with equal amounts of the keyhole limpet hemocyanin-peptide conjugate. The injections were repeated every 3-4 weeks. After three injections, the rabbits' serum titers against the peptide were measured using the ELISA technique. A typical result is shown in Fig. 1 , where the titer against BSA-glutaraldehyde-peptide is compared to that against BSA-glutaraldehyde-lysine. The results indicate that a relatively high titer of antibodies that are specific for the synthetic peptide was obtained. The titers of the four rabbits injected with the hemocyanin-peptide conjugate were nearly identical when measured either by the ELISA or by using peptide labeled with [1251]-Bolton-Hunter reagent (data not shown). Thus, the rabbits reacted quite uniformly to the keyhole limpet hemocyanin-peptide immunogen.
Precipitation of 32P-Labeled ppS6 with Antipeptide Antibodies. The affinity-purified antipeptide antibodies specifically immunoprecipitate 32P-labeled pp56 from a detergent extract of LSTRA cells (Fig. 2) . The reaction between the with the indicated serum dilutions and the protein A-alkaline phosphatase conjugate, the bound phosphatase was assayed using pnitrophenylphosphate as a substrate. Aliquots from each sample well were diluted 10-to 20-fold into 10 mM NaOH before the optical density at 405 nm was measured.
antibodies and pp56 is specific; the precipitation of pp56 is completely inhibited by preincubation of the antibodies with synthetic peptide antigen. The antibodies precipitate pp56 effectively; approximately half of the 32P-labeled pp56 that was present in the initial extract was recovered in the immunoprecipitate under the conditions used (Fig. 2) .
Relative Level of ppS6 in LSTRA Cells. In vitro phosphorylation of pp56 has been observed for cell lines other than LSTRA (12 (Fig. 3) . The sample from the LSTRA cells contained a very heavily labeled species with a molecular weight of 56,000 that corresponds to pp56. Preincubation of the antibodies with the peptide antigen abolished the labeling of this protein, demonstrating the specificity of the interaction between the antibodies and pp56. The level of pp56 was much lower in the sample from YAC-1 cells. When the amounts of radioactivity in the bands containing pp56 from the two cell types were compared, it was found that the level of pp56 was 10-to 20-fold higher in LSTRA cells than in YAC-1 cells. Thus, the quantitation with the antibody corresponds well with the relative levels of pp56 assessed by in vitro phosphorylation (12) . In addition to pp56, two other proteins are specifically labeled by the antipeptide antibodies. These proteins have molecular weights of approximately 60,000 and 70,000. The antibody interaction with these two proteins is specific: these bands are not labeled if the antibodies are preincubated with peptide. The labeling of these two proteins is low and we have not attempted to identify them, although the molecular weight and apparently low level of occurrence of the 60,000-dalton protein raise the possibility that it is cellular pp6Osrc. It is important to note that the 60,000-and 70,000-dalton proteins are detected at equal levels in the LSTRA and YAC-1 cells. In terms of proteins recognized by the antipeptide antibodies, the only difference seen between these two cell types is the much greater level of pp56 in the LSTRA cells.
A B
Inhibition of LSTRA Cell Tyrosine Protein Kinase by Antipeptide Antibodies. Synthetic peptides have been used to generate site-specific antibodies against several regions of various tyrosine protein kinases (14, (20) (21) (22) (23) . In some instances, these antibodies inhibited the kinase activity of the enzymes (14, 22) . We therefore tested the antibodies against the site of tyrosine phosphorylation for their effect on the tyrosine protein kinase activity that is present in detergent extracts of LSTRA cells. We reasoned that if the elevated level of tyrosine protein kinase activity in LSTRA cells is due to the elevated level of pp56, then the interaction of the antipeptide antibodies with pp56 may inhibit this activity.
The antipeptide antibodies do indeed inhibit most of the tyrosine protein kinase activity in the detergent extract of the particulate fraction from LSTRA cells (Fig. 4) . The inhibition is specific since it is completely prevented by preincubation of the antibodies with the synthetic peptide antigen. Although the peptide antigen was also used as the substrate in the kinase assay, the differences shown in Fig. 4 could not be due to the peptide binding to the antibodies since the amount of peptide in the assay is in great excess over the amount of antibody. As might be expected, the antibodies also specifically inhibit the endogenous phosphorylation of pp56 in the detergent extracts (data not shown).
The effect of different amounts of antibody on the kinase activity in the detergent extract from LSTRA cells is shown in Fig. 5 . The activity is sensitive to small amounts of antibody. At maximal inhibition, a residual activity representing about 15% of the initial amount is resistant to inhibition even in the presence of a large excess of antibody. This residual activity could be due to other protein kinases that do not interact with the antipeptide antibodies. Alternatively, the pp56 tyrosine protein kinase could retain some catalytic activity after binding antibody. high-speed centrifugation were extracted with 1% Triton X-100. The extracts were subjected to sodium dodecyl sulfate gel electrophoresis. The proteins were transferred to nitrocellulose and immunoblotting was performed (14) . Affinity-purified antibodies were used at 25 Mg/ml and the immunocomplexes were detected by incubation with '25I-labeled goat antirabbit IgG (2 x 106 cpm/ml). fectively immunoprecipitated 32P-labeled pp56. They also detected this protein in immunoblots. Thus, these antibodies are useful for further studies of pp56. The interaction of pp56 with antibodies generated against a peptide with the sequence of the site of tyrosine phosphorylation in pp6Osr( confirms our observation that this sequence is also present at the site of tyrosine phosphorylation in pp56 (11) .
pp56 was phosphorylated at the site that is recognized by the antipeptide antibodies (see Fig. 2 ), so that even though the antibodies were produced against the unphosphorylated peptide, they recognize the phosphorylated protein. In our previous work, antibodies prepared against sites of phosphorylation in various other proteins by using unphosphorylated peptide as the immunogen did not bind very well to the phosphorylated protein (24, 25) . In the present case, the ability of the antibodies to recognize the phosphorylated form of pp56 implies that the phenolic side chain of the tyrosine that is phosphorylated is not part of the epitope that is recognized by the antipeptide antibodies.
The level of tyrosine protein kinase, as measured using a synthetic peptide substrate, is about 10-fold higher in LSTRA cells than in YAC-1 cells (12) . The antipeptide antibodies inhibit most of the tyrosine protein kinase activity in detergent extracts from LSTRA cells, indicating that these antibodies interact with the tyrosine protein kinase whose activity is increased in these cells. The immunoblot experiment (Fig. 3) does not appear to be the cellular homolog of either of the two viral enzymes with which it shares a common phosphorylation-site sequence, it seems likely that pp56 is another member of the family of tyrosine protein kinases. The observation that tyrosine protein kinases can serve as transforming proteins for a large number of RNA tumor viruses raises the question of the relationship between transformation of the LSTRA cells by the Moloney nmurine leukemia virus and the elevated expression of the pp56 tyrosine protein kinase. The Moloney leukemia virus does not carry an oncogene and pp56 appears to be a cellular enzyme (12) . The mechanism(s) of induction of neoplasms by this virus are not as well defined as those for the avian nonacute transforming viruses. However, recent data suggest that the Moloney leukemia virus, like its avian counterparts, may transform cells by altering the expression of cellular oncogenes through proviral insertion near these genes (28, 29) . For example, some lymphomas induced by this virus in rats have been shown to have the provirus inserted near the myc oncogene (29) . The observation that pp56 shares sequence homology with the transforming proteins of two tumor viruses raises the possibility that the gene for pp56 is also a cellular oncogene. Although an increase in the level of pp56 is not a property common to all cell lines transformed by the Moloney leukemia virus (12) , it is of interest that Voranova et al. (B. M. Sefton, personal communication) have found another Moloney virus-transformed cell line that has an elevated level of pp56. This indicates that the increased expression of pp56 in LSTRA cells may not be due to an event peculiar to this cell line but may occasionally occur as a consequence of infection of cells by the virus. It is thus possible that the elevated level of pp56 in LSTRA cells is the result of integration of the Moloney leukemia provirus near the gene for pp56 and that the enhanced expression of this tyrosine protein kinase causes the transformation of these cells.
Note Added in Proof. The site-specific antibodies described in this paper have been found to inhibit the tyrosine protein kinase activity of both viral and cellular pp6Osrc (unpublished results).
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